health-it is the sole category represented across all 1 tracked stories. Advarra is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Accellacare
health-it is the sole category represented across all 1 tracked stories. Advarra is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. Their average consequence score of 6 runs above the beat's 5.8 for that window. We currently track 1 Healthcare story that mention Accellacare, all published on March 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Accellacare. Shared-story counts are live from our verified record — not editorial picks.
ICON plc and Advarra have unveiled a Research-Ready, Connected Site Network Model designed to bridge the gap between clinical research sites and sponsors. The initiative aims to reduce administrative friction and accelerate drug development through integrated technology and standardized workflows.